Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 705484Generated: October 28, 2026

Hydrochloric Acid → 3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine

https://huagongshe.com/reaction/705484

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantPotassium IodideHCID 4875—
ReactantEthyl BromideHCID 6332—
ReactantN-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamideHCID 72194633—
ReactantN-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetamideHCID 118023019—
CatalystTetrabutylammonium IodideHCID 67553—
SolventWaterHCID 962—
Product3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amineHCID 118022192—

Reaction Steps

3-Chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine (1d) may be prepared through the reaction pathway sequence disclosed in Scheme 4. In step d1, N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)acetamide (1c) may be alkylated with ethyl bromide (EtBr) in the presence of a base, such as sodium hydride (NaH), sodium tert-butoxide (NaOt-Bu), potassium tert-butoxide (KOt-Bu), or potassium tert-amyloxide, in a polar aprotic solvent, such as tetrahydrofuran (THF), at temperatures from about 20° C. to about 40° C., over a period of time of about 60 hours to about 168 hours, to yield N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′). It has been discovered that use of an additive, such as potassium iodide (KI) or tetrabutylammonium iodide (TBAI) decreases the time necessary for the reaction to complete to about 24 hours. It was also discovered that heating the reaction at about 50° C. to about 70° C. in a sealed reactor (to prevent loss of ethyl bromide) decreases the reaction time to about 24 hours. In step d2, N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′) may be treated with hydrochloric acid in water at temperatures from about 70° C. to about 90° C., to yield 3-chloro-N-ethyl-1-(pyridin-3-yl)-1H-pyrazol-amine (1d). The reaction pathway sequence disclosed in Scheme 4 may also be performed without the isolation of N-(3-chloro-1-(pyridin-3-yl)-1H-pyrazol-4-yl)-N-ethylacetamide (1c′).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09174962B2
Source datasetuspto-grants-2015_11
ORD IDord-c9a64461f5cc4812b91e3446ecb8767f
Source noteuspto-grants-2015_11